학술논문
Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study
Document Type
Article
Author
Bamias, A.; Davis, I.D.; Galsky, M.D.; Arranz, J.Á.; Kikuchi, E.; Grande, E.; del Muro, X.G.; Park, S.H.; De Giorgi, U.; Alekseev, B.; Mencinger, M.; Izumi, K.; Schutz, F.A.; Puente, J.; Li, J.-R.; Panni, S.; Gumus, M.; Özgüroğlu, M.; Mariathasan, S.; Poloz, Y.; Bene-Tchaleu, F.; Lee, C.; Bernhard, S.; De Santis, M.
Source
In: The Lancet Oncology . (The Lancet Oncology, January 2024, 25(1):46-61)
Subject
Language
English
ISSN
14745488
14702045
14702045